Where does Myopowers Medical Technologies France SAS rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Myopowers Medical Technologies France SAS ranks #24,837 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Myopowers Medical Technologies France SAS hold?

Myopowers Medical Technologies France SAS holds 11 US utility patents granted between 2015 and 2024, spanning 3 technology areas.

What is Myopowers Medical Technologies France SAS's Innovation Score?

Myopowers Medical Technologies France SAS has an Innovation Score of 47.7 out of 100 (top 18% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Myopowers Medical Technologies France SAS's patent grant rate increasing or decreasing?

Myopowers Medical Technologies France SAS's recent grant velocity is +20% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Myopowers Medical Technologies France SAS's patents?

Myopowers Medical Technologies France SAS's patents average 21.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Myopowers Medical Technologies France SAS

Q: What technology areas does Myopowers Medical Technologies France SAS focus on?

Myopowers Medical Technologies France SAS's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 11 patents, ranking #593 of 3,082 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Q: How is the Myopowers Medical Technologies France SAS patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 11 granted patents across 3 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Myopowers ranks #24,837 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 3 technology areas.

#24,837
of 49,997 US assignees by volume: Top 18%
by Innovation Score (47.7/100): 21.7
avg claims per patent: +20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24837 · Foreign Corporation #24,837 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,837/49,997
PHOTO-FINISH MacroPoint
CPC-NARROW A61F · 3 areas
INNOV-PAR 47.7/100
CLAIMS-DENSE 21.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +20% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: MacroPoint, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Myopowers’s 47.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (18%) Velocity 20.0 pts (42%) Breadth 6.1 pts (13%) Claim depth 13.0 pts (27%)

Qualcomm Incorporated · highest

85
Myopowers Medical… · this assignee

48
3D Lighting… · lowest

7

What this shows Myopowers's Innovation Score is 47.7/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Myopowers?

Each dot is one of Myopowers’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Myopowers’s own 21.7 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Myopowers vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Myopowers's grants concentrate

Myopowers Medical Technologies France SAS is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2015. By volume, Myopowers sits between MSD LLC and Magic Control Technology Corporation.

Myopowers's three-year grant acceleration

Myopowers Medical Technologies France SAS shows 6 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

MSD

11
Multi Trend

11
Multipond Wägetec…

11
Murakumo

11
Macropoint

11
Magarray

11
Maglev Aero

11
Magic Control Tec…

11
Myopowers Medical… ◀

11

What this shows Myopowers holds 11 patents at rank #24,773, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Myopowers

By rank, the assignees closest to #24,773 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Myopowers's primary technology class.

Myopowers's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Myopowers Medical Technologies France SAS patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	9.1%
2017	1	9.1%
2018	1	9.1%
2019	2	18.2%
2022	3	27.3%
2023	1	9.1%
2024	2	18.2%

Which technologies does Myopowers Medical Technologies France SAS patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 11

A61B - DIAGNOSIS; SURGERY; Identification 7

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Myopowers Medical Technologies France SAS's patent record in context - here's where to go next.

Myopowers Medical Technologies France SAS's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #24,837 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Myopowers Medical Technologies France SAS against MSD LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.